Mycophenolate Mofetil Syrup Franchise in Ahmedabad

Mycofoli Syrup Supplier in Mumbai

Immunosuppressant Syrup Distributor in Delhi

Mycophenolate Mofetil Syrup Manufacturer in Bangalore

Transplant Syrup Stockist in Hyderabad
Mycophenolate Mofetil Syrup Exporter in Chandigarh

Home/Products /mycophenolate-mofetil-1000mg-5ml-syrup

Mycofoli Syrup

Composition : Mycophenolate mofetil (1000mg/5ml) Syrup

Dosage Form : Syrup

Packaging Type : Bottle

Packaging : 1gm/5ml

Price : ₹0/-

Please Contact For Best Price

Mycofoli Syrup contains Mycophenolate Mofetil 1000 mg per 5 ml, a potent immunosuppressant widely used in organ transplant medicine to prevent graft rejection. The syrup formulation offers dose flexibility and ease of administration, making it especially suitable for pediatric patients, elderly individuals, and patients with swallowing difficulties.

Mycophenolate mofetil works by selectively inhibiting inosine monophosphate dehydrogenase (IMPDH), thereby suppressing T- and B-lymphocyte proliferation and reducing immune-mediated injury to transplanted organs. This targeted mechanism helps maintain long-term graft survival while minimizing immune overactivity.

Clinically, Mycofoli Syrup is used in renal, hepatic, and cardiac transplant regimens, often in combination with calcineurin inhibitors and corticosteroids, where precise dose titration is essential for safety and therapeutic success.

The syrup ensures consistent bioavailability, accurate dosing, and reliable immunosuppressive control, making it suitable for hospitals, transplant centers, specialty clinics, and pharmacies that manage complex post-transplant care requiring liquid immunosuppressant therapy.

Read More

About the Product

Mycofoli Syrup contains Mycophenolate Mofetil 1000 mg per 5 ml, a potent immunosuppressant widely used in organ transplant medicine to prevent graft rejection. The syrup formulation offers dose flexibility and ease of administration, making it especially suitable for pediatric patients, elderly individuals, and patients with swallowing difficulties.

Mycophenolate mofetil works by selectively inhibiting inosine monophosphate dehydrogenase (IMPDH), thereby suppressing T- and B-lymphocyte proliferation and reducing immune-mediated injury to transplanted organs. This targeted mechanism helps maintain long-term graft survival while minimizing immune overactivity.

Clinically, Mycofoli Syrup is used in renal, hepatic, and cardiac transplant regimens, often in combination with calcineurin inhibitors and corticosteroids, where precise dose titration is essential for safety and therapeutic success.

The syrup ensures consistent bioavailability, accurate dosing, and reliable immunosuppressive control, making it suitable for hospitals, transplant centers, specialty clinics, and pharmacies that manage complex post-transplant care requiring liquid immunosuppressant therapy.

Common side effects may include diarrhea, nausea, vomiting, abdominal pain, headache, and increased susceptibility to infections. Rare but serious adverse effects include leukopenia, anemia, thrombocytopenia, severe infections, and hypersensitivity reactions.

Mycofoli Syrup is indicated for the prevention of organ transplant rejection in renal, cardiac, or hepatic transplant recipients. It may also be used in the management of selected autoimmune disorders, strictly under specialist supervision.

Use Mycofoli Syrup strictly under medical supervision. Regular monitoring of complete blood count, liver and kidney function, and signs of infection is essential. Inform your doctor if you have a history of bone marrow suppression, active infections, or are taking other immunosuppressive medicines. Avoid live vaccines during therapy. Seek immediate medical attention if persistent fever, unusual bleeding, or severe infections occur.

Store Mycofoli Syrup below 25°C in a cool, dry place. Protect from light and moisture. Do not freeze unless specified on the label. Keep out of reach of children and do not use beyond the expiry date.

Get in Touch